1 CRISPR/Cas9 system has become a new versatile technology for genome engineering. It 2 utilizes a single guide RNA (sgRNA) to recognize target sequences in genome function, and 3 activates Cas9 endonucleases to cut the locus. In this study, we designed two target sites from 4 conserved regions of vitamin D receptor (VDR) gene in mammalian cells, which cover more 5 than 17 kb of chromosome region depending on the species. The efficacy of single sgRNA 6 mediated gene specific modification was about 22% to 36%. Concurrently, targeted deletions 7 of the intervening genomic segments were generated in chromosomes when the two sgRNAs 8 worked simultaneously. The large genomic DNA segments ranging from 17.8Kb to 23.4 Kb 9 could be precisely deleted in human and mouse chromosomes. Furthermore, the expression 10 level of 24-hydroxylase (CYP24A1) regulated by VDR was significantly increased in cells 11 treated with VDR CRISPR/Cas9 vectors. This study showed that CRISPR/Cas9 system can be 12 employed to generate large genomic segment deletions in different species, providing 13 sgRNAs are designed within conserved regions. 14
and exon 7 of the mouse orthogonal gene. The two target sites are separated by 23.4kb DNA 1 fragment in human genome and 17.8 kb in mouse genome (Fig.1A) . Therefore, we 2 constructed sgRNA and Cas9 protein co-expression vectors 3 pX330-U6-VDRT1-CBh-hspCas9 and pX330-U6-VDRT2-CBh-hspCas9 for targeting VDR 4 gene in both human and mouse culture cells. 5 In order to enrich genetically modified cells, we designed and established a screening 6 system ( Fig.1B) based on reporter plasmid that could be used to test the transfection 7 efficiency of CRISPR/Cas9 target vectors and enrich target cells simultaneously. In this 8 reporter vector, DsRed gene was used to detect the transfection efficiency, and puromycin 9 resistant gene (Puro R ) and eGFP were used as reporter genes to validate cleavage activity and 10 enrich positive cells. To simulate target sites in genomes, Puro R was separated by the target 11 DNA fragment with PAM sequences flanking two 200bp direct repeats, and therefore, this 12 insertion disrupts its open reading frame. Once designed CRISPR/Cas9 cut the target 13 sequence in the reporter plasmid, the Puro R gene was repaired by SSA-mediated DNA repair 14 mechanism to restore wild-type Puro R , and provided the target cells the ability to survive 15 under puromycin selection pressure in medium. Conversely,, cells without restored Puro R 16 gene were unable to survive in puromycin medium. Therefore, cells with VDR 17 targeted-modification were enriched.
18
Cleavage efficiency of each VDRT sgRNA in HEK293T and C2C12cells 19 In order to test the cleavage efficiency of CRISPR/Cas9 on target sites in conserved 20 sequence of VDR, CRISPR/Cas9 expression vectors and their corresponding report plasmids 21 were co-transfected into human 293T cells. After transfection 24h, Red fluorescence and 22 green fluorescence positive cells were observed ( Fig. 2A) . Meanwhile, puromycin was added 23 into the medium for screening and enrichment of positive clones for 48h, and cells were 24 harvested to extract total genome DNA for further analysis. CRISPR/Cas9-induced VDR 25 indels were measured using T7 endonuclease I (T7E1), which cleaves heteroduplexes formed respectively (Fig. 2B ). In addition, the mutation frequencies of the VT1 and VT2 sites in 1 enriched C2C12 cells were 26% and 22% by T7E1 assay. 2 To further confirm the mutation frequency induced via CRISPR/Cas9, we cloned the 3 PCR product surrounding the target sites amplified from these enriched cells. Ten clones from 4 each human VDRT1 and VDRT2 sites were randomly picked for direct DNA sequencing. 5 The sequencing results demonstrated that random indels were detected in 4 colonies of 6 VDRT1 and 2 colonies of VDRT2, respectively ( Fig.3A and B ). Deletion of 9nt was observed 7 in two independent colonies of VDRT1, though 7nt deletion was verified in only 1 colony. 8 Additionally, 44nt insertion was also found in VDRT1. By comparison, only deletions of 1 nt 9 and 4nt were detected in VDRT2 site. However, mutations from twenty clones were not 10 observed at VDRT1 and VDRT2 in mouse C2C12 cells.
11
Highly efficient large fragment deletion in VDR using CRISPR/Cas9 12 After verifying each single sgRNA activity on VDRT1 and VDRT2 target sites, we 13 contemplated whether we could delete the large chromosome segment between VDRT1 and 14 VDRT2 sites by co-transfecting plasmids expressing two sgRNAs in addition to Cas9. We 15 examined the efficiency of deleting the large chromosome segment in both human and mouse 16 cells. One pair of primers, VDRT1PF and VDRT2PF, which are located upstream of the 17 VDRT1 site and downstream of the VDRT2 site respectively, was used to amplify VDR 18 chromosome DNA. If a large DNA fragment had been deleted from the chromosome, a 500bp 19 DNA fragment was amplified. Otherwise, no product could be amplified when wild-type 20 chromosomes were used as templates. After being enriched with puromycin for 72h, the 21 transfected cells were harvested and the genomic DNA was prepared for PCR amplification. Fig 4A, we detected roughly 500bp PCR products using primers VDRT1PF and 23 VDRT2PF from Cas9 treated cell genome DNA, and no products were obtained using 24 wild-type cell genomes as templates ( Fig.4A ).
As shown in

25
Furthermore, deletion efficiency was measured via gradient dilution assay. In this assay, 26 gradient dilution genomic DNA samples were used as a template for PCR to detect the target 27 fragment and a wild-type gene. PCR products from each dilution point would be revealed by 28 gel electrophoresis. In this study, the positive PCR products of wild-type gene were detected 1 up to the concentration of 3.3ng genome DNA reaction, and the target fragments of large 2 fragment deletion VDR gave positive PCRs up to the dilution containing 33ng of DNA 3 (Fig.4B) . Therefore, the frequencies of large fragment deletions reached 10% at VDR locus in 4 human cells. Subsequently, PCR products sequencing results confirmed a 23.4Kb deletion 5 in human and 17.8Kb deletions in mouse chromosomes, respectively. Compared with 6 wild-type sequences, truncated VDR target sites and random indels were observed between 7 VDR1 and VDR2 target sites in both human and mouse chromosomes ( Fig.4 C) .
8 Expression levels of VDR and Cyp24A1 in the target cells 9 We analyzed the expression level of VDR and 24-hydroxylase (Cyp24A1) to detect the 10 effect of VDR target deletion in 293T cells. The CYP24A1 enzyme catalyzes the first step in 11 the catabolic pathway, converting 1α,25 (OH) 2 D3 into the less active intermediate 12 between VDRT1 and VDRT2 sites in HEK293T cells as well as C2C12 cells. CRISPR/Cas9 1 induced VDRT1 mutation efficiency via NHEJ in 293T cell was 36%, which was much 2 higher than the mutation rate in C2C12 cells (26%). Meanwhile, CRISPR/Cas9 mediated 3 VDRT2 modified efficiency was 30% and 21% in human and mouse cells, respectively.
4
Obviously, these nucleases worked far more efficiently in human 293T cells than mouse 5 C2C12 cells. We speculated that different positions of VDR target sites in human and mouse 6 chromosome might affect CRISPR/Cas9 cleavage activities. Thus, these results suggest that 7 chromosomal structure might play an important role in regulation of CRISPR/Cas9 activity.
8
Another reasonable factor for this phenomenon is the difference of PAM sequences for 9 identical sites in HEK293T and C2C12 cell lines, in which TGG as PAM sequence for 10 VDRT1 and VDRT2 in human genome, and GGG and CGG PAM sequences for VDRT1 and 11 VDRT2 in mouse genome. Though we cannot confidently conclude that the cleavage effect 12 mediated by TGG PAM sequence was higher than GGG or CGG, our results indicate that 13 PAM sequences may play a critical role in the activity of CRISPR/Cas9 system. 14 In this study, there were any mutant alleles in 20 clones of mouse VDR target, but the 15 results of the T7E1 assay indicate that VDR alleles were mutated in cultured mouse cells. We 16 thought that three reasons should been consider: firstly, the plasmid transfection efficiency 17 was very low in mouse cells, and the positive mouse cells were very limited by enrichment.
18
Secondly, T7E1 assay is a direct and coarse approach in mutation detection, and the detecting 19 results may be inconsistent with the sequencing. Another, the "flanking" sequences of target 20 sites may impact the result from T7E1 assay. process.
10
Off-target mutations and chromosomal translocations could lead to adverse biological 11 effects, such as gene mutation, inactivation of tumor suppressors, and activation of oncogenes.
12
Previous studies reported that high off-target effects were detected in the whole genome, sequencing can measure off-target mutations that occur at frequencies ranging from 0.01% to 22 0.1%. Thus, the six potential off-target sites should be subject to further evaluation via more 23 suitable methods.
24
To further analyze the off-target sequences, the two sites with obvious off target effect 25 all possess AGG PAM motif, and these mismatches were not in the "seed sequence". For the 26 other six potential off-target sites, some sites have no NGG PAM while some mismatches 
